Study links normal stem cells to aggressive prostate cancer
A study that revealed new findings about prostate cells may point to future strategies for treating aggressive and therapy-resistant forms of prostate cancer.
The study proved that the prostate basal cell layer contains adult stem cells which possess a unique gene expression profile resembling the deadliest form of prostate cancer. The research was led by Âé¶¹Ó³» MD Anderson Cancer Center with findings published...

Cancer specialists honored for excellence in patient care and research
Nearly 50 faculty members at Âé¶¹Ó³» MD Anderson Cancer Center were honored for their exceptional efforts in the fight against...
Making Cancer History? in Sarasota
Âé¶¹Ó³» MD Anderson Cancer Center returns to Sarasota, Fla. March 5 for its signature Making Cancer History? Seminar. Renowned...
MD Anderson receives $14 million in CPRIT research funding to recruit top talent
Âé¶¹Ó³» MD Anderson Cancer Center was awarded $14 million this week from the Cancer Prevention and Research Institute of Texas (CPRIT) for the recruitment of three cancer scientists. The awards include $12 million for recruitment of two senior researchers and $2 million for a first-time, tenure-track faculty member
The awards accounted for 54 percent of the $26 million CPRIT awarded this week for recruitment of...

MD Anderson researchers propose new staging for HPV-related oropharyngeal cancer
Human papillomavirus (HPV) status is a strong predictor of prognosis for patients with oropharyngeal carcinoma (OPC), but the current staging...
First-in-class drug ONC201shows potential for some blood cancers
ONC201, an anti-cancer drug that?triggers cell death in various tumor types, may have clinical potential for some?blood cancers...
MD Anderson¡¯s Making Cancer History? Seminar returns to Palm Beach
Âé¶¹Ó³» MD Anderson Cancer Center will share novel research findings, cancer prevention tips and advances driven by the institution...
MD Anderson shares in $13.4 million award to study treatment for low-grade DCIS
Prospective, randomized trial will compare surgery, active surveillance; evaluate quality of life
____________________________________...